Insulinotropin

Drug Profile

Insulinotropin

Alternative Names: GLP-1 (7-37); Glucagon-like peptide-1 (7-37)

Latest Information Update: 14 Feb 2008

Price : $50

At a glance

  • Originator Massachusetts General Hospital
  • Developer Scios
  • Class Glucagon-like peptides
  • Mechanism of Action Glucagon-like peptide 1 stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Diabetes mellitus

Most Recent Events

  • 13 Jul 2001 No-Development-Reported for Diabetes mellitus in Denmark (IV-injection)
  • 13 Jul 2001 No-Development-Reported for Diabetes mellitus in USA (Unknown route)
  • 16 Sep 1999 A study has been added to the pharmacodynamics and adverse events sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top